- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Cancer, Metastatic
Total 55985 results
-
Five Prime Therapeutics, Inc.No longer available
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
Predictive BiosciencesCompletedBladder Cancer RecurrenceUnited States
-
Benha UniversityRecruiting
-
David D'AndreaCompleted
-
VitadxFONDATION FORCE POUR L'INNOVATION ET LA RECHERCHE EN SANTE; SATT Paris SaclayCompleted
-
Mansoura UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterPfizerCompletedBladder Cancer | Urinary BladderUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruiting177Lu-DOTA-FAPI | 68Ga-DOTA-FAPI | TheranosticChina
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant | Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation | Infiltrating Bladder Urothelial Carcinoma With Squamous... and other conditionsUnited States
-
Symphogen A/SActive, not recruitingSolid Tumor | Metastatic CancerUnited States, Canada, France, Spain
-
University of Texas Southwestern Medical CenterCompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Lahey ClinicRecruitingCancer | Urinary Bladder Cancer | Urothelial Cancer | Bladder NeoplasmsUnited States
-
RemeGen Co., Ltd.Not yet recruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
AstraZenecaParexelRecruitingNon-Muscle- Invasive Bladder CancerUnited States
-
University of Texas Southwestern Medical CenterRecruitingNon-muscle-invasive Bladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
Istari Oncology, Inc.Active, not recruitingSolid Tumor | Bladder Cancer | Non-muscle-invasive Bladder CancerUnited States
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
RenJi HospitalCompleted
-
National Cancer Institute (NCI)CompletedMetastatic Urethral Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage III Ureter Cancer AJCC v7 | Stage III Urethral Cancer AJCC v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage IV Ureter Cancer AJCC v7 | Stage IV Urethral Cancer AJCC v7 | Ureter Urothelial Carcinoma and other conditionsUnited States, Canada
-
M.D. Anderson Cancer CenterTerminatedProstate Cancer | Bladder Cancer | Genitourinary CancerUnited States
-
Hospital Universitario de FuenlabradaRecruitingBladder Cancer | Urothelial Carcinoma Recurrent | Bladder Urothelial Carcinoma | Bladder Neoplasm | Bladder Cancer StageSpain
-
University of Michigan Rogel Cancer CenterCompletedGenetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance StudyBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic Solid Tumors of Metastatic DiseaseUnited States
-
National and Kapodistrian University of AthensCompleted
-
Genomic Health®, Inc.CompletedNon-muscle Invasive Bladder CancerUnited States
-
Savino M. Di StasiUniversity of BariCompletedLower Urinary Tract Symptoms | Superficial Bladder CancerItaly
-
Prof. Dr. Thomas OttoCompletedAdvanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.Germany
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder CancerUnited States, Israel
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Johns Hopkins UniversityRecruitingNon-Muscle Invasive Bladder CancerUnited States
-
Binhui Biopharmaceutical Co., Ltd.RecruitingNon-muscle-invasive Bladder CancerChina
-
ImmunityBio, Inc.Active, not recruitingNon Muscle Invasive Bladder CancerUnited States
-
Fundacio PuigvertKARL STORZ Endoscopy-America, Inc.RecruitingBladder Cancer | Urothelial Carcinoma BladderSpain
-
University Hospital Bispebjerg and FrederiksbergUnknownBladder CancerDenmark
-
Copenhagen University Hospital at HerlevUnknown
-
Ankara Training and Research HospitalCompletedDisease Progression | Bladder Cancer | Recurrent Bladder Cancer
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingRecurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial CarcinomaUnited States
-
Theralase Inc.University Health Network, Toronto; WCCT Global; Medelis Inc.CompletedNon-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCGCanada
-
Bozyaka Training and Research HospitalUnknownRecurrent Superficial Bladder Cancer | Distilled WaterTurkey
-
The Netherlands Cancer InstituteKarolinska Institutet; Radboud University Medical Center; University Medical... and other collaboratorsRecruitingBladder CarcinomaNetherlands
-
Emory UniversityOlympusCompletedBladder CancerUnited States
-
Spectrum Pharmaceuticals, IncCompleted